 |
Hydrazines - Diagnostic use
Research News and Information
Monday, November 23, 2009
29 Jun 2009 
Membrane type-1 matrix metalloproteinase (MT1-MMP) expressed on the tumor cell surface activates pro-MMP-2 and pro-MMP-13 to exacerbate the malignancy, suggesting its suitability as a target molecule for diagnosis by in vivo molecular imaging. Thus, ... Read more...
Use of fluorescence indicators in receptor ligands.
30 Dec 2008 
Fluorescence techniques can provide insights into the environment of fluorescent indicators incorporated within a ligand as it is bound to its receptor. Fluorescent indicators of different sizes and chemical characteristics ranging from hydrophilic ... Read more...
Breast tumor targeting with (99m)Tc-HYNIC-PR81 complex as a new biologic radiopharmaceutical.
29 Sep 2008 Human epithelial mucin, MUC1, is commonly overexpressed in adenocarcinoma that includes more than 80% of breast cancers. The PR81 is a murine anti-MUC1 monoclonal antibody (MAb) that was prepared against the human breast cancer. We developed an ... Read more...
Latest indexed articles for 'Hydrazines - Diagnostic use'
These are the very latest articles for this heading:
- Development of a radiolabeled probe for detecting membrane type-1 matrix metalloproteinase on malignant tumors. 29 Jun 2009
- Use of fluorescence indicators in receptor ligands. 30 Dec 2008
- Breast tumor targeting with (99m)Tc-HYNIC-PR81 complex as a new biologic radiopharmaceutical. 29 Sep 2008
- Salivary free radical-scavenging activity is affected by physical and mental activities. 30 Aug 2008
- Imaging of cancer cells by multiphoton microscopy using gold nanoparticles and fluorescent dyes. 29 Apr 2008
- Optimization of flow cytometric measurement of ZAP-70 in chronic lymphocytic leukemia. 28 Feb 2008
- Synthesis of oxytocin HYNIC derivatives as potential diagnostic agents for breast cancer. 30 Jul 2007
- PET imaging of infection with a HYNIC-conjugated LTB4 antagonist labeled with F-18 via hydrazone formation. 3 Jul 2007
- An improved method of 18F peptide labeling: hydrazone formation with HYNIC-conjugated c(RGDyK). 10 Jun 2006
- Annexin V SPECT imaging of phosphatidylserine expression in patients with dementia. 23 Apr 2006
- New tacrine-hydrazinonicotinamide hybrids as acetylcholinesterase inhibitors of potential interest for the early diagnostics of Alzheimer's disease. 30 Mar 2006
- Effects of prolonged hypobaric hypoxia on carotid nerve endings and glomus cells. Changes in intercellular coupling. 8 Feb 2006
- [99mTc] HYNIC-hEGF, a potential agent for imaging of EGF receptors in vivo: preparation and pre-clinical evaluation. 30 May 2005
- Isoflavonoids from Astragalus mongholicus protect PC12 cells from toxicity induced by L-glutamate. 6 Apr 2005
- Two phases of zymogen granule lifetime in mouse pancreas: ghost granules linger after exocytosis of contents. 4 Jan 2005
- 2-[(18)F]-fluoroisonicotinic acid hydrazide: biological evaluation in an acute infection model. 30 May 2004
- 99mTc-Hynic-Annexin V. North American Scientific.
28 Feb 2004 - Antimutagenic and antiradical properties of flavones from the roots of Scutellaria baicalensis georgi. 30 Jan 2004
- An improved external loop resonator for in vivo L-band EPR spectroscopy. 30 Aug 2003
- Long-term stimulation of mouse hippocampal slice culture on microelectrode array. 29 Apr 2003
See a longer list of these articles.
Technical information about 'Hydrazines'
Registry Number: 0
Descriptor UI: D006834
Alternative terms: Hydrazines;
Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;
Tree Number: D02.442;
Technical Notes: do not confuse with HYDRAZONES